122 related articles for article (PubMed ID: 6632176)
21. Sleep apnea, norepinephrine-release rate, and daytime hypertension.
Ziegler MG; Nelesen R; Mills P; Ancoli-Israel S; Kennedy B; Dimsdale JE
Sleep; 1997 Mar; 20(3):224-31. PubMed ID: 9178918
[TBL] [Abstract][Full Text] [Related]
22. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension.
Campese VM; Romoff MS; Levitan D; Saglikes Y; Friedler RM; Massry SG
Kidney Int; 1982 Feb; 21(2):371-8. PubMed ID: 7069999
[TBL] [Abstract][Full Text] [Related]
23. Plasma catecholamines during paroxysmal neurogenic hypertension in quadriplegic man.
Mathias CJ; Christensen NJ; Corbett JL; Frankel HL; Spalding JM
Circ Res; 1976 Aug; 39(2):204-8. PubMed ID: 939005
[TBL] [Abstract][Full Text] [Related]
24. Adrenergic activity and peripheral hemodynamics in relation to sodium sensitivity in patients with essential hypertension.
Koolen MI; van Brummelen P
Hypertension; 1984; 6(6 Pt 1):820-5. PubMed ID: 6519741
[TBL] [Abstract][Full Text] [Related]
25. The role of epinephrine in essential hypertension.
Nezu M; Miura Y; Adachi M; Adachi M; Kimura S; Toriyabe S; Ishizuka Y; Ohashi H; Sugawara T; Takahashi M
Jpn Circ J; 1983 Oct; 47(10):1242-6. PubMed ID: 6632177
[TBL] [Abstract][Full Text] [Related]
26. The relationship between potassium balance and circulating catecholamines in essential hypertension.
Cerasola G; Morici ML; Cottone S; Grasso L; D'Ignoto G
Boll Soc Ital Biol Sper; 1984 Jun; 60(6):1111-7. PubMed ID: 6477727
[TBL] [Abstract][Full Text] [Related]
27. Age-dependence of hypertensive-normotensive differences in plasma norepinephrine.
Goldstein DS; Lake CR; Chernow B; Ziegler MG; Coleman MD; Taylor AA; Mitchell JR; Kopin IJ; Keiser HR
Hypertension; 1983; 5(1):100-4. PubMed ID: 6848457
[TBL] [Abstract][Full Text] [Related]
28. Antihypertensive mechanism of diuretic treatment with chlorthalidone. Complementary roles of sympathetic axis and sodium.
Weidmann P; Beretta-Piccoli C; Meier A; Keusch G; Glück Z; Ziegler WH
Kidney Int; 1983 Feb; 23(2):320-6. PubMed ID: 6341684
[TBL] [Abstract][Full Text] [Related]
29. Effect of acute volume alterations on norepinephrine and dopamine-beta-hydroxylase in normotensive and hypertensive subjects.
Lake CR; Ziegler MG
Circulation; 1978 Apr; 57(4):774-8. PubMed ID: 630687
[TBL] [Abstract][Full Text] [Related]
30. Sodium-sensitive hypertension is not associated with higher sympathetic nervous system activity in older hypertensive humans.
Brown MD; Hogikyan RV; Dengel DR; Supiano MA
Am J Hypertens; 2000 Aug; 13(8):873-83. PubMed ID: 10950395
[TBL] [Abstract][Full Text] [Related]
31. Sympathetic nervous system activity and alpha-adrenergic responsiveness in older hypertensive humans.
Supiano MA; Hogikyan RV; Sidani MA; Galecki AT; Krueger JL
Am J Physiol; 1999 Mar; 276(3):E519-28. PubMed ID: 10070019
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular responsiveness to norepinephrine in mild essential hypertension.
Lenders JW; De Boo T; Lemmens WA; Willemsen JJ; Thien T
Am J Cardiol; 1989 May; 63(17):1231-4. PubMed ID: 2711993
[TBL] [Abstract][Full Text] [Related]
33. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation.
Schlaich MP; Lambert E; Kaye DM; Krozowski Z; Campbell DJ; Lambert G; Hastings J; Aggarwal A; Esler MD
Hypertension; 2004 Feb; 43(2):169-75. PubMed ID: 14610101
[TBL] [Abstract][Full Text] [Related]
34. Effects of sodium supplementation during energy restriction on plasma norepinephrine levels in obese women.
Gougeon R; Mitchell TH; Larivière F; Abraham G; Montambault M; Marliss EB
J Clin Endocrinol Metab; 1991 Nov; 73(5):975-81. PubMed ID: 1939535
[TBL] [Abstract][Full Text] [Related]
35. Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man.
Veith RC; Best JD; Halter JB
J Clin Endocrinol Metab; 1984 Jul; 59(1):151-5. PubMed ID: 6725520
[TBL] [Abstract][Full Text] [Related]
36. Dopaminergic control of circadian norepinephrine levels in patients with essential hypertension.
Sowers JR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1133-7. PubMed ID: 7298797
[TBL] [Abstract][Full Text] [Related]
37. Norepinephrine-related mechanism in hypertension accompanying renal failure.
Schohn D; Weidmann P; Jahn H; Beretta-Piccoli C
Kidney Int; 1985 Nov; 28(5):814-22. PubMed ID: 4087696
[TBL] [Abstract][Full Text] [Related]
38. Blood pressure, heart rate, and plasma catecholamines in normal and hypertensive children and their siblings at rest and after standing.
McCrory WW; Klein AA; Rosenthal RA
Hypertension; 1982; 4(4):507-13. PubMed ID: 7152630
[TBL] [Abstract][Full Text] [Related]
39. Effect of pentobarbital anesthesia on plasma norepinephrine kinetics in dogs.
Best JD; Taborsky GJ; Flatness DE; Halter JB
Endocrinology; 1984 Sep; 115(3):853-7. PubMed ID: 6378605
[TBL] [Abstract][Full Text] [Related]
40. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension.
Chang PC; Kriek E; van Brummelen P
J Hypertens; 1994 Feb; 12(2):179-90. PubMed ID: 8021470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
